Adam C. Betz, M.D., is the medical director of CVICU and extracorporeal membrane oxygenation (ECMO) at Oklahoma Heart Institute at Hillcrest Medical Center. He specializes in cardiac critical care, including ECMO, ventricular assist device (VAD) management, and complex cardiothoracic and vascular surgeries.
Euglycemic DKA
Objectives:
- Identify euglycemic DKA as distinct from DKA.
- Identify risk factors for euglycemic DKA.
- State the mechanism of occurrence of euglycemic DKA.
- Identify methods to mitigate the risk of and treat euglycemic DKA.